Ciprofloxacin as ocular liposomal hydrogel

AAPS PharmSciTech

Volumn 11, Issue 1, 2010, Pages 241-246

  Hosny, Khaled Mohamed ^a  

^a BENI SUEF UNIVERSITY   (Egypt)

Author keywords

Ciprofloxacin; Hydrogel; Liposome; Ocular drug delivery system; Transcorneal permeation

Indexed keywords

CARBOPOL 940; CHOLESTEROL; CIPROFLOXACIN; DICETYL PHOSPHATE; LIPOSOME; OCTADECYLAMINE; PHOSPHATIDYLCHOLINE; POLYMER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA PERMEABILITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ENCAPSULATION; HYDROGEL; NONHUMAN; PRIORITY JOURNAL;

AMINES; ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; CIPROFLOXACIN; EYE; HYDROGEL; LIPOSOMES; PHOSPHATIDYLCHOLINES; RABBITS;

EID: 77950917976     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-009-9373-4     Document Type: Article

References (45)

1. CL Le Bourlais L Acar H Zia PA Sado T Needham, et al. 1998 Ophthalmic drug delivery systems-recent advances Prog Retin Eye Res 17 35 58
2. J Sultana R Jain M Agil A Ali 2006 Review of ocular drug delivery Curr Drug Deliv 3 207 217 10.2174/156720106776359186 1:CAS:528:DC%2BD28XjvFWiur0%3D 16611007 (Pubitemid 43725018)
3. L Budai M Hajdu M Budai P Grof S Beni, et al. 2007 Gels and liposomes in optimized ocular drug delivery: studies on ciprofloxacin formulations Int J Pharm 343 34 40 10.1016/j.ijpharm.2007.04.013 1:CAS:528:DC%2BD2sXpsl2iu78%3D 17537601 (Pubitemid 47334864)
4. I Cochereau-Massin J Bauchet S Marrakchi-Benjaafar A Saleh-Mghir F Faurisson, et al. 1993 Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis Antimicrob Agents Chemother 37 633 636 1:CAS:528:DyaK3sXisVOjsL0%3D 8388193
5. JP Adenis J Colin P Verin P Saint-Blancat F Malet 1995 Ciprofloxacin ophthalmic solution versus rifamycin ophthalmic solution for the treatment of conjunctivitis and blepharitis Eur J Ophthalmol 5 82 87 1:STN:280: DyaK28%2FjsFSksA%3D%3D 7549447
6. JP Diamond L White JP Leeming H Bing Hoh DL Easty 1995 Topical 0.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration Br J Ophthalmol 79 606 609 10.1136/bjo.79.6.606 1:STN:280:DyaK2Mzlt1Gqsg%3D%3D 7626579
7. RD Gross RO Hoffman RN Lindsay 1997 A comparison of ciprofloxacin and tobramycin in bacterial conjunctivitis in children Clin Pediatr (Phila) 36 435 444 10.1177/000992289703600801 1:STN:280:DyaK2svhvVeisw%3D%3D
8. A Jauch M Fsadni G Gamba 1999 Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis Graefes Arch Clin Exp Ophthalmol 237 705 713 10.1007/s004170050300 1:CAS:528:DyaK1MXmt1Wmurk%3D 10447643 (Pubitemid 29405716)
9. NA Chaudhry HW Flynn TG Murray H Tabandeh MO Mello, et al. 1999 Emerging ciprofloxacin resistant Pseudomonas aeruginosa Am J Ophthalmol 128 509 510 10.1016/S0002-9394(99)00196-8 1:STN:280:DC%2BD3c%2FktlGhug%3D%3D 10577596 (Pubitemid 29479329)
10. P Garg S Sharma GN Rao 1999 Ciprofloxacin resistant Pseudomonas keratitis Ophthalmology 106 1319 1323 10.1016/S0161-6420(99)00717-4 1:STN:280: DyaK1MzjtlaksA%3D%3D 10406614
11. PC Appelbaum PA Hunter 2000 The fluoroquinolone antibacterials: past, present, and future perspectives Int J Antimicrob Agents 16 5 15 10.1016/S0924-8579(00)00192-8 1:CAS:528:DC%2BD3cXlvV2htrk%3D 11185413 (Pubitemid 30665419)
12. DM Campoli-Richards JP Monk A Price 1988 Ciprofloxacin. A review of its antibiobacterial activity, pharmacokinetic properties and therapeutic use Drugs 35 373 447 10.2165/00003495-198835040-00003 1:CAS:528:DyaL1cXktVSjurk%3D 3292209
13. MA Kalam A Sultana A Samad A Ali M Aqil, et al. 2008 Gelrite-based in vitro gelation ophthalmic drug delivery system of ciprofloxacin J Disp Sci Tech 29 89 96 10.1080/01932690701688482 1:CAS:528:DC%2BD2sXhsVelsL3L
14. HH Lin S-M Ko LR Hsu YH Tsai 1996 The preparation of norfloxacinloaded liposomes and their in vitro evaluation in pig's eye J Pharm Pharmacol 48 801 805 1:CAS:528:DyaK28XmtFKrtbc%3D 8887728
15. B Wiechens D Neumann JB Grammer U Pleyer J Hedderich GI Duncker 1998-99 Retinal toxicity of liposome-incorporated and free ofloxacin after intravitreal injection in rabbit eyes Int Ophthalmol 22 133 143 10.1023/A:1006137100444
16. AD Bangham MM Standish JC Watkins 1965 Diffusion of univalent ions across the lamellae of swollen phospholipids J Mol Biol 13 238 252 10.1016/S0022-2836(65)80093-6 1:CAS:528:DyaF2MXkvVWru7g%3D 5859039
17. G Gregoriadis AT Florence 1993 Liposomes in drug delivery: clinical, diagnostic and ophthalmic potential Drugs 45 15 28 10.2165/00003495-199345010- 00003 1:CAS:528:DyaK3sXktFGitbk%3D 7680982 (Pubitemid 23093890)
18. E Farkas R Schubert R Zelk'o 2004 Effect of cholesterol on the characteristics of vesicular gels containing chlorhexidine Int J Pharm 278 63 70 10.1016/j.ijpharm.2004.02.022 1:CAS:528:DC%2BD2cXktFOitLk%3D 15158949 (Pubitemid 38670437)
19. IP Kaur A Garg AK Singla D Aggarwal 2004 Vesicular systems in ocular drug delivery: an overview Int J Pharm 269 1 14 10.1016/j.ijpharm.2003.09.016 1:CAS:528:DC%2BD3sXpvFeks7k%3D 14698571 (Pubitemid 38035207)
20. M Foradada J Estelrich 1995 Encapsulation of thioguanine in liposomes Int J Pharm 124 261 269 10.1016/0378-5173(95)00097-3 1:CAS:528:DyaK2MXnslygs7o%3D
21. KB Choudhari V Labhasetwar AK Dorle 1994 Liposomes as a carrier for oral administration of insulin: effect of formulation factors J Microencapsul 11 319 325 10.3109/02652049409040461 1:CAS:528:DyaK2cXkvFWntL4%3D 8064555 (Pubitemid 24148441)
22. R Galovic Rengel K Barisic Z Pavelic T Zanic Grubisic I Cepelak, et al. 2002 High efficiency entrapment of superoxide dismutase into mucoadhesive chitosan-coated liposomes Eur J Pharm Sci 15 441 448 10.1016/S0928-0987(02) 00030-1 1:CAS:528:DC%2BD38XktVeisrY%3D 12036721 (Pubitemid 34563308)
23. E Karathanasis AL Ayyagari R Bhavane RV Bellamkonda AV Annapragada 2005 Preparation of in vivo cleavable agglomerated liposomes suitable for modulated pulmonary drug delivery J Contr Release 103 159 175 10.1016/j.jconrel.2004.11. 009 1:CAS:528:DC%2BD2MXhtleqtLg%3D (Pubitemid 40248570)
24. T Nii F Ishii 2005 Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method Int J Pharm 298 198 205 10.1016/j.ijpharm.2005.04.029 1:CAS:528: DC%2BD2MXlsVCksbg%3D 15951143 (Pubitemid 40828340)
25. FJ Aranda JA Teruel A Ortiz 2005 Further aspects on the hemolytic activity of the antibiotic lipopeptide iturin A Biochim Biophys Acta 1713 51 56 10.1016/j.bbamem.2005.05.003 1:CAS:528:DC%2BD2MXlsFGis78%3D 15949788 (Pubitemid 40835982)
26. SL Law HY Hung 1998 Properties of acyclovir-containing liposomes for potential ocular delivery Int J Pharm 161 253 259 10.1016/S0378-5173(97)00362-1 1:CAS:528:DyaK1cXhvFKhsbo%3D (Pubitemid 28095709)
27. MS El-Samaligy NN Nagia EA Mahmoud 2006 Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation Int J Pharm 308 140 148 10.1016/j.ijpharm.2005.11.006 1:CAS:528:DC%2BD28Xls1Srtg%3D%3D 16356669 (Pubitemid 43097245)
28. F Szoka D Papahodjopoulos 1978 Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation Proc Natl Acad Sci USA 75 4194 4198 10.1073/pnas.75.9.4194 1:CAS:528: DyaE1MXhvVOhsA%3D%3D 279908
29. M Malhotra DK Majumdar 1997 In vitro transcorneal permeation of ketorolac tromethamine from buffered and unbuffered aqueous ocular drops Indian J Exp Biol 35 941 947 1:CAS:528:DyaK2sXmvFaqtbo%3D 9475074 (Pubitemid 27446120)
30. J du Plessis C Ramachandran N Weiner DG Muller 1996 The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage Int J Pharm 127 273 278 10.1016/0378-5173(95)04281-4 (Pubitemid 26091011)
31. P Perugini F Pavanetto 1998 Liposomes containing boronophenylalanine for boron neutron capture therapy J Microencapsul 15 473 483 10.3109/ 02652049809006874 1:CAS:528:DyaK1cXjvF2ntb0%3D 9651869 (Pubitemid 28288736)
32. New RRC. Liposomes: a practical approach. Oxford: Oxford University Press; 1990.
33. M Gulati M Grover M Singh S Singh 1998 Study of azathioprine encapsulation into liposomes J Microencapsul 15 485 494 10.3109/ 02652049809006875 1:CAS:528:DyaK1cXjvF2nur4%3D 9651870
34. P Srinath SP Vyas VD Prakash 2000 Preparation and pharmacodynamic evaluation of liposomes of indomethacin Drug Dev Ind Pharm 26 313 321 10.1081/DDC-100100359 1:CAS:528:DC%2BD3cXitVamt74%3D 10738648 (Pubitemid 30164746)
35. MH Rania M Samar DM Nahed SG Ahmed 2007 Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies AAPS Pharm Sci Tech 8 1 1 12 10.1208/pt0802027
36. MS Nagarsenker VY Londhe GD Nadkarni 1999 Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery Int J Pharm 190 63 71 10.1016/S0378-5173(99)00265-3 1:CAS:528:DyaK1MXmvVart7s%3D 10528098 (Pubitemid 29467473)
37. Gruner SM. Materials properties of liposomal bilayers. In: Ostro MJ, editor. Liposomes from biophysics to therapeutics. New York: Marcel Dekker; 1997. p. 1-38.
38. MS Nagarsenker VY Londhe 2003 Preparation and evaluation of a liposomal formulation of sodium cromoglicate Int J Pharm 251 49 56 10.1016/S0378-5173(02) 00583-5 1:CAS:528:DC%2BD3sXis1Whtg%3D%3D 12527174 (Pubitemid 36071459)
39. R Peschka C Dennehy FCJ Szoka 1998 A simple in vitro model to study the release kinetics of liposome encapsulated material J Control Release 56 41 51 10.1016/S0168-3659(98)00067-4 1:CAS:528:DyaK1cXntVGhtbw%3D 9801428 (Pubitemid 28511125)
40. AM Durrani NM Davies M Thomas IW Kellaway 1992 Pilocarpine bioavailability from a mucoadhesive liposomal ophthalmic drug delivery system Int J Pharm 88 409 415 10.1016/0378-5173(92)90340-8 1:CAS:528: DyaK3sXms1Ontw%3D%3D (Pubitemid 23000445)
41. K Singh M Mezei 1983 Liposomal ophthalmic drug delivery system. I. Triamcinolone acetonide Int J Pharm 16 339 344 10.1016/0378-5173(83)90152-7 1:CAS:528:DyaL2cXht1Gqtg%3D%3D (Pubitemid 13010893)
42. VH Lee PT Urrea RE Smith D Schazlin 1985 Therapeutic review: ocular drug bioavailability from topically applied liposomes Surv Ophthalmol 29 335 348 10.1016/0039-6257(85)90109-2 1:CAS:528:DyaL2MXkt1Oisr8%3D 3992472 (Pubitemid 15115495)
43. HE Schaeffer DL Krohn 1982 Liposomes in topical drug delivery Invest Ophthalmol Vis Sci 22 220 227 1:CAS:528:DyaL38XhsV2isrk%3D 7056633
44. A Deepika PK Indu 2005 Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system Int J Pharm 290 155 159 10.1016/j.ijpharm.2004.10.026 (Pubitemid 40139055)
45. IP Kaur R Smitha 2002 Penetration enhancers and ocular bioadhesives: two new avenues for ophthalmic drug delivery Drug Dev Ind Pharm 28 353 369 10.1081/DDC-120002997 1:CAS:528:DC%2BD38XktFCktbs%3D 12056529 (Pubitemid 34547874)